Vascular Damage in Kidney Disease: Beyond Hypertension
Open Access
- 1 January 2011
- journal article
- Published by Hindawi Limited in International Journal of Hypertension
- Vol. 2011, 1-5
Abstract
Chronic kidney disease (CKD) is highly prevalent and a multiplier of cardiovascular disease (CVD) and cannot be completely explained by traditional Framinghan risk factors. Consequently, greater emphasis has been placed in nontraditional risk factors, such as inflammation, endothelial dysfunction, sympathetic overactivation, protein-energy wasting oxidative stress, vascular calcification, and volume overload. The accumulation of uremic toxins (and the involvement of genetic factors) is responsible for many of the clinical consequences of a condition known as uremia. In this brief paper, we discuss mechanisms involved in the vascular damage of CKD patients, aiming to point out that important factors beyond hypertension are largely responsible for endothelial activation and increased CVD risk, with potential impact on risk stratification and development of novel therapeutic options.Keywords
This publication has 45 references indexed in Scilit:
- Does Uremia Cause Vascular DysfunctionKidney and Blood Pressure Research, 2011
- Therapeutic Strategies for Heart Failure in Cardiorenal SyndromesAmerican Journal of Kidney Diseases, 2010
- Chronic kidney disease: a public health priority and harbinger of premature cardiovascular diseaseJournal of Internal Medicine, 2010
- p-Cresol and Cardiovascular Risk in Mild-to-Moderate Kidney DiseaseClinical Journal of the American Society of Nephrology, 2010
- Increased Plasma and Endothelial Cell Expression of Chemokines and Adhesion Molecules in Chronic Kidney DiseaseNephron Clinical Practice, 2009
- Role of stromal cell-derived factor 1 (SDF1/CXCL12) in regulating anterior pituitary functionJournal of Molecular Endocrinology, 2006
- Hemodialysis Modulates Gene Expression Profile in Skeletal MuscleAmerican Journal of Kidney Diseases, 2006
- Protecting the endothelium: A new focus for management of chronic kidney diseaseHemodialysis International, 2006
- Advanced Glycation End Product Cross‐Linking: Pathophysiologic Role and Therapeutic Target in Cardiovascular DiseaseCongestive Heart Failure, 2004
- Review on uremic toxins: Classification, concentration, and interindividual variabilityKidney International, 2003